Welcome to the international HTA database

Showing [23378 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2006	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Selegiline transdermal patch
2012	HAYES, Inc.	Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
1999	Health Council of the Netherlands Gezondheidsraad (GR)	Selenium and its compounds: evaluation of the effects on reproduction, recommendation for classification
2010	NIHR Health Technology Assessment programme	Self monitoring of blood glucose in type 2 diabetes
1999	Agency for Healthcare Research and Quality (AHRQ)	Self-administered drug treatments for acute migraine headache
2018	NIHR Health Technology Assessment programme	Self-care support for children and adolescents with long-term conditions: the REfOCUS evidence synthesis
2014	University of York	Self-care support for people with COPD
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Self-directed cognitive behavioural therapy for adults with diagnosis of depression: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2021	National Institute for Health and Care Excellence (NICE)	Self-expanding implant insertion into the intersphincteric space for faecal incontinence. NICE interventional procedures guidance 685
2006	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Self-expanding metallic stents (SEMS) for relieving malignant colorectal obstruction: a systematic review
2004	National Institute for Clinical Excellence (NICE)	Self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care
2015	Health Quality Ontario (HQO)	Self-management and educational interventions in the postacute stroke population: a rapid review
2018	NIHR Health Technology Assessment programme	Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial
2013	Health Quality Ontario (HQO)	Self-management support interventions for persons with chronic disease: an evidence-based analysis
2017	NIHR Health Technology Assessment programme	Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2012	Agency for Healthcare Research and Quality (AHRQ)	Self-measured blood pressure monitoring: comparative effectiveness
2019	Swiss Federal Office of Public Health (FOPH)	Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2006	HAYES, Inc.	Self-monitoring and self-management of oral anticoagulant therapy
2002	HAYES, Inc.	Self-monitoring of oral anticoagulant therapy
2007	The Swedish Council on Health Technology Assessment (SBU)	Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert)
2021	National Institute for Health and Care Excellence (NICE)	Selinexor with low-dose dexamethasone for treating refractory multiple myeloma (terminated appraisal). NICE technology appraisal guidance 700
2022	National Institute for Health and Care Excellence (NICE)	Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer. NICE technology appraisal guidance 760
2021	National Institute for Health and Care Excellence (NICE)	Selpercatinib for treating advanced thyroid cancer with RET alterations. NICE technology appraisal guidance 742
2023	National Institute for Health and Care Excellence (NICE)	Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer. NICE technology appraisal guidance 911
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib for metastatic uveal melanoma – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line
2020	National Institute for Health and Care Excellence (NICE)	SEM Scanner 200 for preventing pressure ulcers. NICE medical technologies guidance 51
2023	Canadian Agency for Drugs and Technologies in Health (CADTH)	Semaglutide 2 mg for type 2 diabetes
2023	National Institute for Health and Care Excellence (NICE)	Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal). NICE technology appraisal guidance 910
2023	National Institute for Health and Care Excellence (NICE)	Semaglutide for managing overweight and obesity. NICE technology appraisal guidance 875
2005	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2002	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2011	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Semi-implantable, middle ear hearing aids
2011	HAYES, Inc.	Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2013	HAYES, Inc.	SensiGene fetal RHD genotyping
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Sensimed triggerfish® for 24-hour monitoring of changes in intraocular pressure in glaucoma
2009	NIHR Health Technology Assessment programme	Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SensiumVitals® vital signs monitoring patch
2022	NIHR Health Technology Assessment programme	Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCT
2000	HAYES, Inc.	Sensory integration therapy for children with learning disabilities
2004	HAYES, Inc.	Sensory integration therapy for children with learning disabilities or developmental delays
2014	HAYES, Inc.	Sensory integration therapy for non-autistic children
2003	Wessex Institute for Health Research and Development (WIHRD)	Sensory or auditory integration therapy for children with autistic spectrum disorders
2011	HAYES, Inc.	Sensory-based treatments for autism spectrum disorders
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ for sentinel lymph node localisation in breast cancer
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer
2006	Medical Services Advisory Committee (MSAC)	Sentinel lymph node biopsy in breast cancer
2013	NIHR Health Technology Assessment programme	Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation
2002	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Sentinel node biopsy (SNB) in breast cancer - progress report
2000	ECRI	Sentinel node biopsy for staging breast cancer
2001	HAYES, Inc.	Sentinel node biopsy for the staging of breast cancer
2005	HAYES, Inc.	Sentinel node biopsy for the staging of breast cancer
2019	National Institute for Health and Care Excellence (NICE)	Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. NICE medical technologies guidance 41
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Separate instrument sets for prevention of tumor seeding during tumor resection and flap surgery
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for nonuterine abdominal adhesions
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of uterine adhesions
2016	NIHR Health Technology Assessment programme	Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation
2016	National Institute for Health and Care Excellence (NICE)	SepsiTest assay for rapidly identifying bloodstream bacteria and fungi. NICE diagnostics guidance 20
2012	HAYES, Inc.	Septin 9 (SEPT9) methylation analysis for colorectal cancer
2006	National Institute for Health and Care Excellence (NICE)	Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome
2006	National Institute for Health and Care Excellence (NICE)	Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome. NICE interventional procedures guidance 199
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2012	Blue Cross Blue Shield Association (BCBS)	Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2010	National Institute for Health and Care Excellence (NICE)	SeQuent Please balloon catheter for in-stent coronary restenosis
2005	Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ)	Sequential antibiotic treatment of pneumonia - primary research
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Seralite® for multiple myeloma and other B cell dyscrasias
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Serenity System® to treat tinnitus
2002	Blue Cross Blue Shield Association (BCBS)	Serial endpoint testing for the diagnosis and treatment of allergic disorders
2011	HAYES, Inc.	Serial Transverse Enteroplasty (STEP) for short bowel syndrome
2007	National Institute for Health and Care Excellence (NICE)	Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children. NICE interventional procedures guidance 232
2017	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with HPV vaccination
2019	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with influenza vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with oral cholera vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with yellow fever vaccination
2003	HAYES, Inc.	Serologic assays for the diagnosis and management of inflammatory bowel disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2002	Institute for Clinical Systems Improvement (ICSI)	Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2006	HAYES, Inc.	Serum carcinoembryonic antigen (CEA) assay for diagnosis of ovarian cancer
2012	Agency for Healthcare Research and Quality (AHRQ)	Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias
2003	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Serum markers of fibrosis and inflammation in chronichepatitis C - systematic review, expert panel
2004	Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT)	Serum markers of fibrosis and inflammation in chronichepatitis C - update of previous report
2007	NIHR Horizon Scanning Centre (NIHR HSC)	Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2008	Quality Improvement Scotland (NHS QIS )	Service delivery organisation for acute low back pain
2024	NIHR Health Services and Delivery Research programme	Service design for children and young people with common mental health problems: literature review, service mapping and collective case study
2003	Adelaide Health Technology Assessment (AHTA)	Service improvement tools for the prevention, diagnosis and management of chronic diseases
2024	NIHR Health Services and Delivery Research programme	Service innovations for people with multiple long-term conditions: reflections of a rapid evaluation team
2015	NIHR Health Services and Delivery Research programme	Service user engagement and health service reconfiguration: a rapid evidence synthesis
2000	Israel Center for Technology Assessment in Health Care (ICTAHC)	Setting priorities for the adoption of health technologies on a national level - the Israeli experience
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sevelamer in patients with end-stage renal disease: a systematic review and economic evaluation
2012	Institute for Clinical Evaluative Sciences (ICES)	Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario